Exelixis (EXEL) Total Current Liabilities (2010 - 2026)
Exelixis (EXEL) reported Total Current Liabilities of $361.93 million for Q2 2027, up 7.7% from $336.11 million a year earlier but down 2.4% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Total Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2026, Exelixis posted Total Current Liabilities of $405.64 million, up 0.5% from FY2025.
- Total Current Liabilities has a five-year compound annual growth rate of 3.7% (FY2021 to FY2026).
- By year, Total Current Liabilities came in at $403.77 million in FY2025, $394.28 million in FY2023 (+21.6%) and $324.36 million in FY2022 (-3.9%).
- Five-year quarterly Total Current Liabilities spans a low of $336.11 million in Q2 2026 and a high of $405.64 million in Q4 2026.
- Year over year, Total Current Liabilities gained in three of the last six quarters, with an average year-over-year change of 0.0%.
- Per Business Quant data, the three quarters before Q2 2027 came in at $370.98 million (Q1 2027), $405.64 million (Q4 2026) and $373.78 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Exelixis | 14.53 Bn | 10.86 Bn | 608.03 Mn | 361.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 361.93 Mn |
| Apr 3, 2026 | 370.98 Mn |
| Jan 2, 2026 | 405.64 Mn |
| Oct 3, 2025 | 373.78 Mn |
| Jul 4, 2025 | 336.11 Mn |
| Apr 4, 2025 | 399.10 Mn |
| Jan 3, 2025 | 403.77 Mn |
| Sep 27, 2024 | 394.35 Mn |
| Jun 28, 2024 | 345.70 Mn |
| Mar 29, 2024 | 373.01 Mn |
| Dec 29, 2023 | 394.28 Mn |
| Sep 29, 2023 | 376.82 Mn |
| Jun 30, 2023 | 339.62 Mn |
| Mar 31, 2023 | 327.60 Mn |
| Dec 30, 2022 | 324.36 Mn |
| Sep 30, 2022 | 301.73 Mn |
| Jul 1, 2022 | 304.52 Mn |
| Apr 1, 2022 | 289.08 Mn |
| Dec 31, 2021 | 337.59 Mn |
| Oct 1, 2021 | 269.51 Mn |
API Access
Exelixis Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();